Pralsetinib
Pralsetinib (BLU-667) is a potent and selective RET kinase inhibitor effective against wild-type RET, multiple mutants (V804L, V804M, M918T), and the CCDC6-RET fusion. It is a valuable research tool for investigating RET-driven pathologies, with demonstrated activity in both cellular assays and in vivo models of RET-altered cancers.
Product Specifications
CAS Number
2097132-94-8
Product Name Alternative
Inhibitor, inhibit, cRET, Blu667, BLU-667, BLU 667, Pralsetinib, RET
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
97.88% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.18 mM) ; DMSO:126.25 mg/mL (236.6 mM)
Smiles
CO[C@]1 (CC[C@@H] (CC1) c1nc (C) cc (Nc2cc (C) [nH]n2) n1) C (=O) N[C@@H] (C) c1ccc (nc1) -n1cc (F) cn1
Molecular Formula
C27H32FN9O2
Molecular Weight
533.6
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GLMN, CT (GLMN, FAP48, FAP68, VMGLOM, Glomulin, FK506-binding protein-associated protein, FKBP-associated protein) (FITC)
GLMN, CT (GLMN, FAP48, FAP68, VMGLOM, Glomulin, FK506-binding protein-associated protein, FKBP-associated protein) (FITC)
